ClinicalTrials.Veeva
Menu

Find clinical trials for Lymphoma in Boston, MA

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Lymphoma
Leukemia
Non-Hodgkin Lymphoma
Lymphoid Leukemia
Diffuse Large B-Cell Lymphoma
Precursor Cell Lymphoblastic Leukemia-Lymphoma
B-Cell Chronic Lymphocytic Leukemia

Lymphoma trials near Boston, MA, USA:

Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma

glofitamab and obinutuzumab is in treating patients with Follicular Lymphoma (FL) and Marginal Zone Lymphoma (MZL) who have not rec...

Enrolling
Indolent Non-hodgkin Lymphoma
Marginal Zone Lymphoma
Drug: Obinutuzumab
Drug: Glofitamab

Phase 2

Reid Merryman, MD

Boston, Massachusetts, United States and 2 other locations

In this research study is looking to see how safe and effective belantamab mafodotin is in relapsed or refractory plasmablastic lymphoma or ...

Enrolling
Refractory Plasmablastic Lymphoma
Anaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma
Drug: Belantamab Mafodotin

Phase 2

Jacob Soumerai, MD

Boston, Massachusetts, United States and 2 other locations

is in treating participants with relapse or refractory Follicular Lymphoma (FL).* The names of the study drugs involved in this research stu...

Begins enrollment in 1 month
Refractory Lymphoma
Follicular Lymphoma
Drug: Epcoritamab
Drug: Rituximab

Phase 2

Reid Merryman, MD

Boston, Massachusetts, United States and 1 other location

therapy in treating relapsed/refractory central nervous system (CNS) lymphoma, systemic lymphoma with concurrent CNS lymphoma...

Active, not recruiting
Lymphoma Cns
Lymphoma
Drug: Cyclophosphamide
Biological: Axicabtagene Ciloleucel

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 1 other location

chemotherapy as a possible treatment for peripheral T-Cell Lymphoma (PTCL).The name of the study drugs involved in this study are:* Tazemeto...

Begins enrollment in 3 months
Enteropathy-Associated T-Cell Lymphoma
Angioimmunoblastic T-cell Lymphoma
Drug: Vincristine
Drug: Tazemetostat

Phase 2

Eric Jacobsen, MD

Boston, Massachusetts, United States and 2 other locations

Status recently updated

This research is being done to see if epcoritamab is effective in treating follicular lymphoma as a second line of treatment.The name of the...

Not yet enrolling
Enrolling
Lymphoma,Non-Hodgkin
Follicular Lymphoma
Drug: Epcoritamab

Phase 2

Beth Israel Lahey Health
Beth Israel Lahey Health

Boston, Massachusetts, United States

is effective in treating participants with untreated Marginal Zone Lymphoma (MZL).The names of the study drugs involved in this study are:* ...

Begins enrollment this month
Marginal Zone Lymphoma
Lymphoma
Drug: Venetoclax
Drug: Rituximab

Phase 2

Gottfried von Keudell, MD PhD

Boston, Massachusetts, United States

of rituximab and epcoritamab is in treating patients with Follicular Lymphoma (FL) and who have not received other treatments for their lymphoma...

Enrolling
Low Grade Non-Hodgkin's Lymphoma, Adult
Follicular Lymphoma
Drug: Rituximab
Drug: Epcoritamab

Phase 2

Reid Merryman, MD

Boston, Massachusetts, United States and 2 other locations

This research study is studying several new investigational drug combinations as a possible treatment for follicular lymphoma.The drugs invo...

Active, not recruiting
Follicular Lymphoma
Drug: Rituximab
Drug: PF04518600

Phase 1

Dana-Farber Cancer Institute
Dana-Farber Cancer Institute

Boston, Massachusetts, United States and 5 other locations

Adult T-cell leukemia/lymphoma (ATLL) is a rare form of cancer found mostly among people from the Caribbean islands, Western Africa, Brazil,...

Active, not recruiting
Lymphoma
Adult T-Cell Leukemia/Lymphoma
Drug: CHEP
Drug: Brentuximab Vedotin

Phase 2

UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center

Boston, Massachusetts, United States and 3 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems